PAR 41.5% 46.0¢ paradigm biopharmaceuticals limited..

Results out last week of June snd based on it's recent history...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 739 Posts.
    lightbulb Created with Sketch. 1
    Results out last week of June snd based on it's recent history of 20% runs before falling back 10% then tracking sideways for a week or so, we could well see 70-75c by 2-3rd week of Jun??....that large piece at 64c that I bit into on tue had suddenly disappeared by wed morn.....not looking likely that sellers are going to feed into bids so buyers are going to have to pay up if they want a piece of this before end of June?

    If results show that PPS is equally as effective at controlling hayfever symptoms then this will be 1st non-steroid based nasal spray.....pharma will then look to fund P3 trial in order to get a preferential licensing deal??.....offers could make current mcap look very cheap??

    I bought into this because of the effects that PPS has on joint health/inflammation in animals (as a veterinarian that uses this just about daily across many types of joint disease), so cannot see why this won't work as regards the two joint trials PAR has running/underway. If the hayfever trial results are good then this opens up potential trials for other allergic disease such as skin allergies and IBD (inflammatory bowel disease)....these are very very big markets,

    Kind regards, SEAH.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.135(41.5%)
Mkt cap ! $82.30M
Open High Low Value Volume
34.0¢ 49.5¢ 34.0¢ $3.506M 8.474M

Buyers (Bids)

No. Vol. Price($)
1 10000 45.5¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 147167 1
View Market Depth
Last trade - 16.10pm 25/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.